Comorbidity and Its Impact on Patients with COVID-19
The coronavirus disease may have an impact on the health of infected individuals depending on their pre-existing comorbidities. An overview of the association between comorbidities and disease aggravation in COVID-19 patients that might result in poor clinical outcomes or death, is provided here. Additionally, general medical issues are discussed, including the symptoms that individuals infected with SARS-CoV-2 may exhibit. Persons with COVID-19 who also have concomitant comorbidities like diabetes mellitus or hypertension are at a higher risk of experiencing a more severe course and progression of the illness. Additionally, older patients with comorbidities particularly those 65 years of age and older, had a higher rate of ICU admissions and COVID-19 disease mortality. A total of 355 hospitalized COVID-19 patients were identified from four dedicated COVID hospitals. Total death among the hospitalized COVID-19 patients was 8.7%, among them 83.8% was >65 years old and 80.6% had comorbidities. Comorbid patients typically have the worst prognosis, thus they should take every care to prevent contracting SARS CoV-2.
Authors
- Tamanna Bahar (ORCID: https://orcid.org/0000-0003-2731-1290)
- Muhammad Nazrul Islam (ORCID: https://orcid.org/0000-0002-7189-4879)
- Goutam Kumar Acherjya (ORCID: https://orcid.org/0000-0001-9809-4997)
- Keya Tarafder
- Md. Ashraful Haque Chowdhury
- Mohammad Ali (ORCID: https://orcid.org/0000-0002-6035-4076)
- Mohammad Wasim (ORCID: https://orcid.org/0000-0002-4803-5558)
- Salina Haque
Publication Details
- Journal
- SAS Journal of Medicine
- Published
- 2025-03-06
- DOI
- https://doi.org/10.36347/sasjm.2025.v11i03.003
- Citations
- 3
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 0.00